TransMedics Group, Inc. (TMDX)
Sector: Healthcare
Industry: Electromedical & Electrotherapeutic Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $3.00B
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Latest financial period: June 30, 2026
Filed with the SEC: August 4, 2026
Estimated earnings date: November 4, 2026
Profit #244 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 83.3% | 86.4% | 91.0% | 77.7% |
Growth #251 of 1484 companies
Payout #1117 of 1484 companies
Safety #1209 of 1484 companies
Price #795 of 1484 companies
